TLSA Earnings & Financial Statements
Tiziana Life Sciences Ltd
$1.13
+$0.03(+2.73%)
38
Overall
40
Value
54
Tech
21
Quality
Market Cap
$139.99M
Volume
443.29K
52W Range
$0.76 - $2.33
Target Price
$8.00
TLSA earnings and financial statements: Tiziana Life Sciences Ltd's income statement, balance sheet and cash flow statement, annual and quarterly.
TLSA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | -$13.31M |
| Operating income | -$21.13M | -$15.79M | -$17.98M | -$13.76M | -$26.48M |
| EBITDA | -$18.20M | -$13.09M | - | -$15.40M | -$31.13M |
| Net income | -$18.43M | -$8.33M | -$16.79M | -$18.98M | -$27.89M |
| EPS (diluted) | - | $-0.11 | $-0.17 | $-0.30 | $-0.48 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $11.49M | $11.28M | $12.18M | $26.48M | $48.83M |
| Total liabilities | $11.44M | $7.35M | $6.65M | $6.91M | $7.55M |
| Shareholders’ equity | $52.0K | $3.94M | $5.54M | -$96.80M | -$78.67M |
| Cash and equivalents | $4.01M | $3.72M | $1.18M | $18.12M | $42.19M |
| Long-term debt | $234.0K | - | $109.0K | $243.0K | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$12.85M | -$1.53M | -$15.70M | -$19.61M | -$21.76M |
| Capital expenditure | - | - | - | - | -$22.0K |
| Free cash flow | -$12.85M | -$1.53M | -$15.70M | -$19.61M | -$21.78M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TLSA | $1.13 | +2.7% | 443.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tiziana Life Sciences Ltd Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW